fMRI detection of early neural dysfunction in preclinical Huntington's disease

Journal of the International Neuropsychological Society

Volumn 13, Issue 5, 2007, Pages 758-769

  Zimbelman, Janice L ^a,b   Paulsen, Jane S ^c   Mikos, Ania ^c   Reynolds, Norman C ^a   Hoffmann, Raymond G ^a   Rao, Stephen M ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Basal ganglia; Early detection; Magnetic resonance imaging; Time reproduction

Indexed keywords

ADULT; ARTICLE; BEHAVIOR DISORDER; BRAIN ATROPHY; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUNTINGTON CHOREA; MALE; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PUTAMEN;

EID: 34548131996     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617707071214     Document Type: Article

References (51)

1. Ashburner, J. & Friston, K.J. (2000). Voxel-based morphometry: The methods. Neuroimage, 11, 805-821.
2. Ashburner, J. & Friston, K.J. (2005). Unified segmentation. Neuroimage, 26, 839-851.
3. Aylward, E.H., Brandt, J., Codori, A.M., Mangus, R.S., Barta, P.E., & Harris, G.J. (1994). Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology, 44, 823-828.
4. Aylward, E.H., Codori, A.M., Barta, P.E., Pearlson, G.D., Harris, G.J., & Brandt, J. (1996). Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Archives of Neurology, 53, 1293-1296.
5. Aylward, E.H., Codori, A.M., Rosenblatt, A., Sherr, M., Brandt, J., Stine, O.C., Barta, P.E., Pearlson, G.D., & Ross, C.A. (2000). Rate of caudate atrophy in presymptomatic and symptomatic, stages of Huntington's disease. Movement Disorders, 15, 552-560.
6. Aylward, E.H., Sparks, B.F., Field, K.M., Yallapragada, V., Shpritz, B.D., Rosenblatt, A., Brandt, J., Gourley, L.M., Liang, K., Zhou, H., Margolis, R.L., & Ross, C.A. (2004). Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology, 63, 66-72.
7. Bartenstein, P., Weindl, A., Spiegel, S, Boecker, H., Wenzel, R., Ceballos-Baumann, A.O., Minoshima, S., & Conrad, B. (1997). Central motor processing in Huntington's disease. A PET study. Brain, 120 (Pt. 9), 1553-1567.
8. Bassett, S.S., Yousem, D.M., Cristinzio, C., Kusevic, I., Yassa, M.A., Caffo, B.S., & Zeger, S.L. (2006). Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain, 129, 1229-1239.
9. Bookheimer, S.Y., Strojwas, M.H., Cohen, M.S., Saunders, A.M., Pericak-Vance, M.A., Mazziotta, J.C., & Small, G.W. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. New England Journal of Medicine, 343, 450-456.
10. Brinkman, R.R., Mezei, M.M., Theilmann, J., Almqvist, E., & Hayden, M.R. (1997). The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. American Journal of Human Genetics, 60, 1202-1210.
11. Campodomico, J.R., Codori, A.M., & Brandt, J. (1996). Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation. Journal of Neurology, Neurosurgery, and Psychiatry, 61, 621-624.
12. Celone, K.A., Calhoun, V.D., Dickerson, B.C., Atri, A., Chua, E.F., Miller, S.L., DePeau, K., Rentz, D.M., Selkoe, D.J., Blacker, D., Albert, M.S., & Sperling, R.A. (2006). Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: An independent component analysis. Journal of Neuroscience, 26, 10222-10231.
13. Cox, R.W.(1906). AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Computers and Biomedical Research, 29, 162-173.
14. Cox, R.W. & Hyde, J.S. (1997). Software tools for analysis and visualization of fMRI data. NMR in Biomedicine, 10, 171-178.
15. Davatzikos, C. (2004). Why voxel-based morphometric analysis should be used with great caution when characterizing group differences. Neuroimage, 23, 17-20.
16. DeKosky, S.T., Ikonomovic, M.D., Styren, S.D., Beckett, L., Wisniewski, S., Bennett, D.A., Cochran, E.J., Kordower, J.H., & Mufson, E.J. (2002). Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Annals of Neurology, 51, 145-155.
17. Elsinger, C.L., Rao, S.M., Zimbelman, J.L., Reynolds, N.C., Blindauer, K.A., & Hoffmann, R.G. (2003). Neural basis for impaired time reproduction in Parkinson's disease: An fMRI study. Journal of the International Neuropsychological Society, 9, 1088-1098.
18. Feigin, A., Leenders, K.L., Moeller, J.R., Missimer, J., Kuenig, G., Spetsieris, P., Antonini, A., & Eidelberg, D. (2001). Metabolic network abnormalities in early Huntington's disease: An [18)F]FDG PET study. Journal of Nuclear Medicine, 42, 1591-1595.
19. Gauthier, L.R., Charrin, B.C., Borrell-Pages, M., Dompierre, J.P., Rangone, H., Cordelieres, F.P., De, M.J., MacDonald, M.E., Lessmann, V., Humbert, S., & Saudou, F. (2004). Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell, 118, 127-138.
20. Good, C.D., Johnsrude, I.S., Ashburner, J., Henson, R.N., Friston, K.J., & Frackowiak, R.S. (2001). A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage, 14, 21-36.
21. Gu, X., Li, C., Wei, W., Lo, V., Gong, S., Li, S.H., Iwasato, T., Itohara, S., Li, X.J., Mody, I., Heintz, N., & Yang, X.W. (2005). Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron, 46, 433-444.
22. Harrington, D.L., Haaland, K.Y., & Hermanowicz, N. (1998). Temporal processing in the basal ganglia. Neuropsychology, 12, 3-12.
23. Harris, G.J., Codori, A.M., Lewis, R.F., Schmidt, E., Bedi, A., & Brandt, J. (1999). Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain, 122 (Pt 9), 1667-1678.
24. Hoshi, E., Tremblay, L., Feger, J., Carras, P.L., & Strick, R. L. (2005). The cerebellum communicates with the basal ganglia. National Neuroscience, 8. 1491-1493.
25. Huntington Study Group, (1996). Unified Huntington's disease Rating Scale: Reliability and consistency. Huntington Study Group. Movement Disorders, 11, 136-142.
26. Ivry, R.B. & Keele, S.W. (1989). Timing functions of the cerebellum. Journal of Cognitive Neuroscience, 1, 134-150.
27. Kirkwood, S.C., Siemers, E., Hodes, M.E., Conneally, P.M., Christian, J.C., & Foroud, T. (2000). Subtle changes among presymptomatic carriers of the Huntington's disease gene. Journal of Neurology Neurosurgery and Psychiatry, 69, 773-779.
28. Kirkwood, S.C., Siemers, E., Stout, J.C., Hodes, M.E., Conneally, P.M., Christian, J.C., & Foroud, T. (1999). Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Archives of Neurology, 56, 563-568.
29. Laforet, G.A., Sapp, E., Chase, K., McIntyre, C., Boyce, F.M., Campbell, M., Cadigan, B.A., Warzecki, L., Tagle, D.A., Reddy, P.H., Cepeda, C., Calvert, C.R., Jokel, E.S., Klapstein, G.J., Ariano, M.A., Levine, M.S., DiFiglia, M., & Aronin, N. (2001). Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. Journal of Neuroscience, 21, 9112-9123.
30. Langbehn, D.R., Brinkman, R.R., Falush, D., Paulsen, J.S., & Hayden, M.R. (2004). A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clincal Genetics, 65, 267-277.
31. Lawrence, A.D., Hodges, J.R., Rosser, A.E., Kershaw, A., Ffrench-Constant, C., Rubinsztein, D.C., Robbins, T.W., & Sahakian, B.J. (1998). Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain, 121 (Pt 7), 1329-1341.
32. Li, S.C., Lindenberger, U., & Sikstrom, S. (2001). Aging cognition: From neurormodulation to representation. Trends in Cognitive Science, 5 479-486.
33. O'Boyle, D.J., Freeman, J.S., & Cody, F.W. (1996). The accuracy and precision of timing of self-paced, repetitive movements in subjects with Parkinson's disease. Brain, 119 (Pt 1), 51-70.
34. Oldfield, R.C. (1971). The assessment and analysis of handedness: The Edinburgh Inventory. Neuropsychologia, 9, 97-113.
35. Paulsen, J.S., Hayden, M., Stout, J.C., Langbehn, D.R., Aylward, E., Ross, C.A., Guttman, M., Nance, M., Kleburtz, K., Oakes, D., Shoulson, I., Kayson, E., Johnson, S.C., Penziner, E., & The Predict Investigators of the HSG (2006a). Preparing for preventive clinical trials: The Predict HD study. Archives in Neurology, 63, 883-890.
36. Paulsen, J.S., Hoth, K.F., Nehl, C., & Stierman, L. (2005). Critical periods of suicide risk in Huntington's disease. American Journal of Psychiatry, 162, 725-731.
37. Paulsen, J.S., Magnotta, V.A., Mikos, A.E., Paulson, H.L., Penziner, E., Andreasen, N.C., & Nopoulos, P.C. (2006b). Brain structure in preclinical Huntington's disease. Biological Psychiatry, 59, 57-63.
38. Paulsen, J.S., Zhao, H., Stout, J.C., Brinkman, R.R., Guttman, M., Ross, C.A., Como, P, Manning, C., Hayden, M.R., & Shoulson, I. (2001). Clinical markers of early disease in persons near onset of Huntington's disease. Neurology, 57, 658-662.
39. Paulsen, J.S., Zimbelman, J.L., Hinton, S.C., Langbehn, D.R., Leveroni, C.L., Benjamin, M.L., Reynolds, N.C., Jr., & Rao, S.M. (2064). An fMRI Biomarker of Early Neuronal Dysfunction in Presymptomatic Huntington's Disease. American Journal of Neuroradiation, 25, 1715-1721.
40. Rajah, M.N. & D'Esposito, M. (2005). Region-specific changes in prefrontal function with age: A review of PET and fMRI studies on working and episodic memory. Brain, 128, 1964-1983.
41. Rao, S.M., Harrington, D.L., Haaland, K.Y., Bobholz, J.A., Cox, R.W., & Binder, J.R. (1997). Distributed neural systems underlying the timing of movements. Journal of Neuroscience, 17, 5528-5535.
42. Rao, S.M., Mayer, A.R., & Harrington, D.L. (2001). The evolution of brain activation during temporal processing. National Neuroscience, 4 317-323.
43. Reading, S.A., Dziorny, A.C., Peroutka, L.A., Schreiber, M., Gourley, L.M., Yallapragada, V., Rosenblatt, A., Margolis, R.L., Pekar, J.J., Pearlson, G.D., Aylward, E., Brandt, J., Bassett, S.S., & Ross C.A. (2004). Functional brain changes in presymptomatic Huntington's disease. Annals of Neurology, 55, 879-883.
44. Reynolds, N.C.Jr., Hellman, R.S., Tikofsky, R.S., Prost, R.W., Mark, L.P., Elejalde, B.R., Lebel, R., Hamsher, K.S., Swanson, S., & Benezra, E.E. (2002). Single photon emission computerized tomography (SPECT) in detecting neurodegeneration in Huntington's disease. Nuclear Medicine Communications, 23, 13-18.
45. Roos, R.A.,.Vegter-van der Vlis, M., Hermans, J., Elshove, H.M., Moll, A.C., van de Kamp, J.J., & Bruyn, G.W. (1991). Age at onset in Huntington's disease: Effect of line of inheritance and patient's sex. Journal of Medical Genetics, 28, 515-519.
46. Rosas, H.D., Hevelone, N.D., Zaleta, A.K., Greve, D.N., Salat, D.H., & Fischl, B. (2005). Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology, 65, 745-747.
47. Talairach, J. & Tournoux, P. (1988). Co-planar Stereotaxic Atlas of the Human Brain. New York: Thieme.
48. The Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell, 72, 971-983.
49. Thieben, M.J., Duggins, A.J., Good, C.D., Gomes, L., Mahant, N., Richards, F., McCusker, E., & Frackowiak, R.S. (2002). The distribution of structural neuropathology in pre-clinical. Huntington's disease. Brain, 125, 1815-1828.
50. Tobin, A,J. & Signer, E.R. (2000). Huntington's disease: The challenge for cell biologists. Trends in Cell Biology, 10, 531-536.
51. Weeks, R.A., Ceballos-Baumann, A., Piccini, P., Boecker, H., Harding, A.E., & Brooks, D.J. (1997). Cortical control of movement in Huntington's disease. A PET activation study. Brain, 120 (Pt 9), 1569-1578.